Vegetarian Softgel Capsules Market Overview

According to recent research conducted by Business Research Insights, Global Vegetarian Softgel Capsules Market size is estimated at USD 0.66 Billion in 2026, set to expand to 1.07 Billion by 2035, growing at a CAGR of 5.57% during the forecast from 2026 to 2035.

The global vegetarian softgel capsules market is expanding rapidly due to increasing consumer preference for plant-based nutraceuticals, pharmaceuticals, and dietary supplements. In 2025, more than 68% of supplement consumers preferred non-animal capsule formulations, while over 52% of manufacturers shifted toward starch- and cellulose-based capsule technologies. Vegetarian softgel capsules are commonly manufactured using tapioca starch, modified corn starch, carrageenan, and hydroxypropyl starch, replacing traditional gelatin derived from bovine and porcine sources. More than 41% of new supplement launches during the last 24 months featured vegan or vegetarian labeling. The market is also supported by growing demand from 1.5 billion vegetarian consumers globally and increasing clean-label product penetration across over 70 countries.

Navigate Market Opportunities with Data-Driven Business Intelligence: Business Research Insights

Business intelligence in the vegetarian softgel capsules market is increasingly driven by production capacity optimization, raw material sourcing analysis, and consumer preference tracking. Over 63% of manufacturers now integrate AI-based forecasting systems for ingredient procurement and capsule production planning. Data analytics indicate that approximately 49% of consumers between ages 22 and 40 actively search for plant-based capsule supplements online before purchasing. In addition, over 37% of pharmaceutical contract manufacturers have upgraded encapsulation facilities to support vegetarian capsule compatibility. Market analysis also reveals that more than 55% of export demand comes from North America and Europe, while Asia-Pacific contributes nearly 46% of total manufacturing volume for vegetarian softgel products globally.

Top 5 Trends in the Vegetarian Softgel Capsules Market

1. Rising Demand for Plant-Based Nutraceuticals

The increasing popularity of plant-based nutrition is significantly boosting vegetarian softgel capsule demand worldwide. More than 61% of consumers in urban markets now prefer supplements labeled vegan, vegetarian, or plant-derived. Products containing omega-3 algae oil, turmeric extract, ashwagandha, and plant proteins increasingly use vegetarian softgel technology. Approximately 44% of nutraceutical launches in 2024 used non-gelatin capsule systems compared to 29% in 2020. Consumer awareness regarding animal-free ingredients has also increased by 38% over the past 5 years. Additionally, more than 72 countries now have active vegan supplement product registrations, increasing market penetration for vegetarian softgel manufacturers globally.

2. Expansion of Clean-Label and Allergen-Free Supplements

Clean-label formulations have become a dominant trend in the vegetarian softgel capsules market. Nearly 58% of global supplement buyers check ingredient labels before purchase, while 47% actively avoid artificial additives and animal-derived ingredients. Manufacturers are developing capsules free from gluten, soy, dairy, preservatives, and synthetic colors. Over 33% of newly developed vegetarian softgels now feature organic certifications and allergen-free claims. Demand for transparent ingredient sourcing has increased by 42% among millennials and Gen Z consumers. In addition, around 29% of healthcare practitioners now recommend clean-label plant-based supplements to patients seeking digestive and immune support solutions.

3. Technological Advancements in Encapsulation

Advanced encapsulation technologies are improving the performance and shelf stability of vegetarian softgel capsules. Modern production systems can now achieve moisture control rates below 6%, improving capsule durability in high-temperature environments. Approximately 36% of manufacturers adopted automated encapsulation systems during the last 3 years to improve production precision and reduce waste. New polysaccharide-based shell technologies have improved oxygen barrier protection by nearly 31%, enhancing product stability for sensitive oils and probiotics. Manufacturers are also reducing capsule leakage rates to below 1.5% through improved seam technology. High-speed encapsulation lines can now produce over 150,000 vegetarian softgels per hour in large-scale facilities.

4. Increasing Pharmaceutical Applications

Vegetarian softgel capsules are gaining popularity in pharmaceutical applications due to improved patient compliance and religious acceptability. Around 48% of pharmaceutical companies developing oral liquid formulations are considering vegetarian softgel alternatives. Plant-based capsules are increasingly used for pain management, vitamin therapies, cardiovascular products, and hormone-related medications. More than 35% of prescription nutraceutical products launched in Europe during 2024 used vegetarian softgel delivery systems. Additionally, over 60 countries have expanded pharmaceutical regulatory frameworks to support vegetarian excipient approvals. Enhanced bioavailability technologies have also improved ingredient absorption efficiency by approximately 27% in lipid-based formulations.

5. Growth of Contract Manufacturing and Private Labeling

Contract manufacturing organizations are expanding vegetarian softgel production capabilities to meet rising global demand. More than 54% of supplement brands now outsource encapsulation processes to specialized manufacturers. Private-label vegan supplements increased by 39% between 2022 and 2025, particularly in North America and Asia-Pacific. Manufacturing facilities are investing heavily in automated filling systems, humidity-controlled rooms, and sustainable packaging lines. Approximately 46% of contract manufacturers now provide customized vegetarian capsule formulations for startups and e-commerce brands. Small and medium supplement companies account for nearly 32% of total private-label vegetarian softgel orders globally, supporting strong long-term production expansion.

Regional Growth and Demand

• North America

North America remains one of the largest consumers of vegetarian softgel capsules due to strong demand for plant-based dietary supplements and pharmaceutical products. The United States accounts for approximately 71% of regional demand, while Canada contributes nearly 18%. Over 64% of supplement consumers in the region prefer vegan or vegetarian delivery formats. More than 42 million adults in the United States regularly consume plant-based nutraceutical products, creating substantial demand for vegetarian softgel technologies.

Manufacturing capacity in North America has expanded significantly, with over 28 new encapsulation facilities upgraded during the last 4 years. Approximately 53% of nutraceutical companies in the region now offer at least one vegetarian softgel product line. The sports nutrition sector contributes nearly 21% of total regional capsule consumption. Additionally, over 35% of pharmacies and healthcare retailers prioritize shelf placement for vegan-certified supplements.

E-commerce growth also supports the market, with online supplement purchases increasing by 47% since 2021. More than 58% of consumers aged 25–45 in North America actively search for clean-label and animal-free products. Regulatory support for plant-based pharmaceutical excipients has improved product approvals across more than 14 major therapeutic categories, further accelerating vegetarian softgel demand.

• Europe

Europe represents a highly developed market for vegetarian softgel capsules due to strict ingredient transparency regulations and increasing vegan population growth. Germany, France, the United Kingdom, Italy, and Spain collectively account for over 67% of regional demand. Approximately 51 million consumers across Europe identify as vegetarian, flexitarian, or vegan, significantly supporting plant-based supplement sales.

More than 49% of newly launched nutraceutical products in Europe during 2024 used vegetarian capsule systems. Demand for clean-label supplements has increased by 44% across Western Europe during the past 5 years. Pharmaceutical companies are increasingly shifting away from animal-derived gelatin due to religious, ethical, and allergen-related concerns.

Europe also leads in sustainability initiatives, with nearly 38% of capsule manufacturers implementing biodegradable and recyclable packaging systems. Around 31% of supplement consumers prioritize environmentally responsible packaging alongside vegan formulations. The region hosts over 120 specialized nutraceutical manufacturing facilities focused on vegetarian encapsulation technologies.

Research investment is also strong, with over 200 active formulation development projects focused on polysaccharide-based capsule technologies. Improved cross-border distribution networks now support vegetarian softgel product availability across more than 30 European countries, driving steady market expansion.

• Asia-Pacific

Asia-Pacific is the fastest-growing production hub for vegetarian softgel capsules due to abundant raw materials, lower manufacturing costs, and rising regional supplement demand. China, India, Japan, South Korea, and Australia collectively contribute nearly 46% of global vegetarian softgel manufacturing output. India alone supplies approximately 34% of global starch-based capsule raw materials.

More than 1 billion consumers in Asia-Pacific follow vegetarian or plant-focused dietary practices, creating strong domestic demand for non-gelatin products. Around 57% of supplement manufacturers in the region expanded production lines between 2022 and 2025. The region also benefits from strong pharmaceutical outsourcing activities, with over 40% of global nutraceutical contract manufacturing occurring in Asia-Pacific facilities.

China operates more than 250 encapsulation production plants, while India hosts over 180 nutraceutical formulation facilities. Demand for herbal supplements, ayurvedic formulations, and algae-based omega products has increased by nearly 36% during the last 3 years. E-commerce supplement sales across Asia-Pacific also rose by approximately 52% since 2021.

Government initiatives supporting pharmaceutical manufacturing modernization have accelerated investment in automated vegetarian capsule technologies. In addition, over 60% of regional startups entering the supplement industry now prioritize vegan capsule delivery systems for product differentiation.

• Middle East & Africa

The Middle East & Africa vegetarian softgel capsules market is expanding steadily due to increasing halal supplement demand, pharmaceutical imports, and health awareness initiatives. Approximately 67% of consumers in Gulf countries prefer non-porcine pharmaceutical products, driving adoption of vegetarian softgel alternatives. Saudi Arabia and the United Arab Emirates collectively account for nearly 48% of regional demand.

Supplement consumption in the Middle East increased by 33% between 2021 and 2025, particularly for immunity, vitamin D, and herbal formulations. Around 41% of healthcare distributors now prioritize halal-certified and vegetarian supplement products. Pharmaceutical importers are increasingly sourcing plant-based capsules to comply with religious and regulatory standards.

Africa is also emerging as a growth market due to expanding urban populations and rising healthcare spending. South Africa, Egypt, and Nigeria contribute nearly 58% of regional supplement demand. More than 24 new nutraceutical manufacturing facilities were established across Africa during the last 5 years.

Regional governments are supporting local pharmaceutical manufacturing, with over 15 industrial healthcare zones currently under development. Demand for affordable plant-based supplements increased by 29% among middle-income consumers. Improved retail pharmacy infrastructure and growing online health product sales are expected to further strengthen vegetarian softgel capsule demand throughout the region.

Top Companies in the Vegetarian Softgel Capsules Market

• Robinson Pharma
• Ayanda
• Bahrain Pharma
• Captek
• Catalent
• Aenova
• Best Formulations
• Procaps Laboratorios
• SIRIO
• EuroCaps

Top Companies Profile and Overview

• Robinson Pharma

Headquarters: California, United States

Robinson Pharma is one of the leading dietary supplement manufacturers in the vegetarian softgel capsules market, operating advanced manufacturing campuses with more than 15 production lines dedicated to softgel, tablet, and capsule formulations. The company serves over 6,000 domestic and international supplement brands and manufactures billions of dosage units annually. Robinson Pharma has significantly expanded its vegetarian softgel capabilities due to growing demand for vegan omega oils, herbal extracts, and plant-based vitamin supplements.

The company focuses heavily on research-driven product innovation, investing in encapsulation systems that improve dissolution speed, ingredient stability, and shelf life. More than 40% of its recently developed products include vegan or vegetarian formulations using tapioca starch and carrageenan-based shells. Robinson Pharma also maintains strict quality assurance standards with advanced microbiological testing, heavy metal screening, and automated optical inspection technologies.

• Ayanda

Headquarters: Pritzwalk, Germany

Ayanda is widely recognized for pioneering vegetarian softgel innovation in the European nutraceutical and pharmaceutical industries. The company specializes in advanced encapsulation technologies designed for highly sensitive active ingredients including probiotics, algae oils, and botanical extracts. Ayanda operates highly automated production systems capable of manufacturing millions of vegetarian softgels per day with precision-controlled oxygen and humidity environments.

The company has focused extensively on sustainable manufacturing initiatives, reducing water consumption by approximately 22% across production facilities during the past 5 years. Ayanda also utilizes advanced shell technologies that improve oxidative stability by nearly 30%, particularly for omega-3 and plant oil formulations. Its vegetarian softgel systems are designed to provide improved transparency, texture consistency, and delayed ingredient degradation.

• Bahrain Pharma

Headquarters: Bahrain

Bahrain Pharma has emerged as an important regional manufacturer within the vegetarian softgel capsules market by focusing on halal-certified and plant-based pharmaceutical formulations. The company operates GMP-compliant facilities equipped with modern encapsulation machinery capable of producing softgel formulations for vitamins, minerals, herbal products, and specialty therapeutic applications.

The company has experienced strong growth in Gulf Cooperation Council countries, where approximately 67% of consumers prefer non-animal pharmaceutical ingredients for religious and dietary reasons. Bahrain Pharma’s vegetarian softgel portfolio includes products formulated with starch-based shells, natural colorants, and preservative-free ingredient systems. More than 45% of the company’s export products are directed toward Middle Eastern healthcare distributors and pharmacies.

• Captek

Headquarters: California, United States

Captek is a major innovator in custom nutrient delivery systems and vegetarian softgel manufacturing technologies. The company develops advanced formulations for dietary supplements, sports nutrition products, and pharmaceutical applications using sophisticated encapsulation engineering. Captek’s production facilities utilize automated systems capable of producing more than 100 million softgel capsules annually.

The company specializes in lipid-based nutrient delivery technologies that improve absorption rates for ingredients such as coenzyme Q10, curcumin, omega oils, and fat-soluble vitamins. Approximately 38% of Captek’s product development pipeline involves vegetarian softgel projects using tapioca and seaweed-derived shell materials. Its advanced formulation expertise allows improved ingredient bioavailability and controlled-release functionality.

• Catalent

Headquarters: New Jersey, United States

Catalent is among the world’s largest providers of pharmaceutical delivery technologies and plays a major role in the vegetarian softgel capsules market. The company operates more than 50 manufacturing and research facilities globally, serving pharmaceutical, biotechnology, and nutraceutical companies. Catalent’s advanced softgel technologies support prescription medicines, over-the-counter supplements, and specialty nutraceutical formulations.

The company invests heavily in plant-based encapsulation research and high-bioavailability delivery systems. Catalent’s vegetarian softgel platforms are increasingly utilized for lipid-based pharmaceutical compounds, probiotics, and high-potency nutraceutical ingredients. More than 25 dedicated softgel production suites operate within Catalent’s global facilities, supporting large-scale manufacturing for multinational healthcare companies.

• Aenova

Headquarters: Starnberg, Germany

Aenova is a prominent contract development and manufacturing organization serving global pharmaceutical and nutraceutical markets with advanced vegetarian softgel technologies. The company operates over 15 manufacturing facilities and supplies products to more than 80 countries. Aenova specializes in oral dosage forms including vegetarian softgels, hard capsules, chewables, and liquid formulations.

The company manufactures billions of dosage units annually and continues investing in automated encapsulation systems to improve manufacturing scalability and precision. Approximately 30% of Aenova’s nutraceutical projects now involve plant-based delivery systems due to increasing customer demand for vegan supplements and clean-label products. Its facilities include specialized production environments for oxygen-sensitive and moisture-sensitive ingredients.

• Best Formulations

Headquarters: California, United States

Best Formulations is a major nutraceutical manufacturer known for producing vegetarian softgel capsules, gummies, powders, and tablet formulations for domestic and international supplement brands. The company operates multiple large-scale manufacturing facilities equipped with high-speed encapsulation systems, automated packaging lines, and advanced quality control laboratories.

The company produces thousands of customized formulations annually and supports product categories including sports nutrition, immunity, beauty supplements, and herbal wellness products. More than 43% of recent formulation requests processed by Best Formulations involved vegan or vegetarian delivery formats. Its vegetarian softgel technologies utilize non-GMO starch-based materials designed for improved stability and transparency.

• Procaps Laboratorios

Headquarters: Barranquilla, Colombia

Procaps Laboratorios is one of Latin America’s largest pharmaceutical and nutraceutical manufacturers specializing in softgel delivery technologies. The company exports products to over 50 countries and operates advanced encapsulation facilities capable of producing millions of capsules daily. Procaps has strengthened its position in the vegetarian softgel capsules market through investments in starch-based shell innovation and high-efficiency production systems.

The company develops products across multiple therapeutic and nutritional categories including cardiovascular health, immune support, gastrointestinal wellness, and botanical supplements. Approximately 32% of its current R&D projects involve vegetarian capsule technologies and enhanced bioavailability solutions. Procaps also focuses on sustainability initiatives including reduced plastic packaging and energy-efficient manufacturing infrastructure.

• SIRIO

Headquarters: Shenzhen, China

SIRIO is a leading global nutraceutical contract manufacturer specializing in vegetarian softgel capsules, gummies, probiotics, and functional nutrition products. The company operates manufacturing facilities across China, Europe, and North America and serves clients in more than 40 countries. SIRIO produces billions of supplement units annually and continues investing heavily in automated production technologies.

The company’s vegetarian softgel portfolio includes algae oil supplements, botanical extracts, sports nutrition products, and beauty-from-within formulations. More than 50% of SIRIO’s export orders now involve vegan or vegetarian formulations due to increasing international consumer demand. Its advanced starch-based encapsulation systems provide improved stability and ingredient protection for oxidation-sensitive compounds.

• EuroCaps

Headquarters: Trebur, Netherlands

EuroCaps is a specialized softgel manufacturer focused on premium-quality nutraceutical and pharmaceutical encapsulation technologies. The company supplies vegetarian softgel solutions for vitamins, omega oils, herbal extracts, and specialty wellness products. EuroCaps operates highly controlled manufacturing facilities equipped with advanced climate management systems and automated inspection technologies.

The company places strong emphasis on sustainability and clean-label manufacturing. Approximately 36% of EuroCaps’ production output now includes vegetarian or vegan-compatible formulations using plant-derived shell materials. Its facilities utilize energy-efficient production systems and environmentally responsible sourcing practices for capsule ingredients and packaging materials.

Conclusion

The vegetarian softgel capsules market continues to expand globally due to rising demand for plant-based nutrition, clean-label supplements, and non-animal pharmaceutical formulations. More than 60% of modern supplement consumers now prefer vegan-compatible delivery systems, while manufacturers across over 70 countries are increasing investment in vegetarian encapsulation technologies. Innovations in starch-based shell materials, oxygen barrier protection, and automated manufacturing systems are improving capsule quality and production efficiency significantly. North America and Europe remain major consumption centers, while Asia-Pacific dominates manufacturing output with nearly half of global production capacity. Increasing pharmaceutical applications, halal certification demand, and private-label supplement growth are expected to further strengthen long-term market opportunities for vegetarian softgel capsule manufacturers worldwide.